Bevacizumab, Gemcitabine, and Oxaliplatin in Treating Patients With Metastatic Pancreatic Cancer
about
Bevacizumab, Gemcitabine, and Oxaliplatin in Treating Patients With Metastatic Pancreatic Cancer
description
clinical trial
@en
klinisch onderzoek
@nl
name
Bevacizumab, Gemcitabine, and ...... h Metastatic Pancreatic Cancer
@en
type
label
Bevacizumab, Gemcitabine, and ...... h Metastatic Pancreatic Cancer
@en
prefLabel
Bevacizumab, Gemcitabine, and ...... h Metastatic Pancreatic Cancer
@en
P4844
P6153
P1476
Phase II Trial of Bevacizumab, ...... atic Pancreatic Adenocarcinoma
@en
P3098
NCT00112528
P580
2005-06-01T00:00:00Z
P582
2006-08-01T00:00:00Z